This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair

This study has been completed.
Information provided by:
Rhode Island Hospital Identifier:
First received: March 21, 2007
Last updated: July 21, 2010
Last verified: July 2010
The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.

Condition Intervention Phase
Laceration Drug: Intranasal ketamine Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair

Resource links provided by NLM:

Further study details as provided by Rhode Island Hospital:

Primary Outcome Measures:
  • Efficacy of sedation (OSBDR) [ Time Frame: 30 minutes ]
  • Time to onset of sedation (Ramsay 6-point Sedation Scale) [ Time Frame: 30 minutes ]

Secondary Outcome Measures:
  • Duration of sedation [ Time Frame: Up to 1 hour ]
  • Primary caregiver satisfaction [ Time Frame: 24 hours ]
  • Physician satisfaction [ Time Frame: Duration of procedure ]
  • Ketamine bioavailability [ Time Frame: 1 hour ]
  • Abnormalities in cardiopulmonary function [ Time Frame: Until time of discharge ]
  • Administration of supplemental sedative medication [ Time Frame: During time required for procedure ]
  • Prolonged sedation (i.e. > 1 hour) [ Time Frame: Until time of discharge from emergency department ]

Estimated Enrollment: 45
Study Start Date: May 2007
Study Completion Date: February 2010
Detailed Description:
Procedural sedation is frequently used to facilitate distressing and painful procedures in the pediatric emergency department. However, administering an intramuscular medication or placing an intravenous line to give intravenous medications can be as distressing as the procedure itself. Oral medications generally take longer to work and are subject to first-pass metabolism. Another alternative is to give the medication by the intranasal route, which only requires a spray into the nose. Ketamine is a good sedative drug with favorable qualities, and is often used intramuscularly or intravenously. It has been used intranasally as a pre-induction by anesthetics, sedation for CT scans, and brief dental procedures, but its use has not yet been demonstrated in the setting of the pediatric emergency department for procedural sedation. We will be comparing three different doses of ketamine, applied intranasally using a mucosal atomization device, and determining if there are any differences in efficacy of sedation, time to onset of sedation, duration of sedation, caregiver and physician satisfaction, and number of adverse events. We will also use this opportunity to determine ketamine bioavailability when given intranasally using the mucosal atomization device.

Ages Eligible for Study:   1 Year to 7 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Children between 1 to 7 years old
  • Simple facial laceration, defined as: linear; requiring two or more sutures; no greater than 5.0 centimeters; does not cross the lid margin of the eye; does not require a plastics/face surgery consult; occured within the last 24 hours.
  • Physician feels that intravenous sedation is required to perform the laceration repair

Exclusion Criteria:

  • Closed head injury, any alteration in level of consciousness, clinical suspicion of intracranial injury or increased intracranial pressure
  • Any conditions that qualify patient as American Society of Anesthesiologists' (ASA) III or IV
  • Known diagnoses of hyperthyroidism or porphyria
  • Glaucoma or penetrating eye injury
  • Hypertension
  • Any contraindication, including drug allergy, to study medications
  • Severe trauma with other injuries requiring operative intervention
  • Abnormal neurological exam in a previously normal child
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00451724

United States, Rhode Island
Hasbro Children's Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Rhode Island Hospital
Principal Investigator: James G Linakis, PhD, MD Rhode Island Hospital
  More Information Identifier: NCT00451724     History of Changes
Other Study ID Numbers: 0014-07
Study First Received: March 21, 2007
Last Updated: July 21, 2010

Keywords provided by Rhode Island Hospital:
Double blinded

Additional relevant MeSH terms:
Wounds and Injuries
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anesthetics, Dissociative
Anesthetics, Intravenous
Anesthetics, General
Central Nervous System Depressants
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action processed this record on September 18, 2017